Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. (Q31906597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

1 reference

1 reference

Martin Radespiel-Tröger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

C Herold

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Heinz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H T Schneider

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Schuppan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E G Hahn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

26-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169069%20AND%20SRC:MED&resulttype=core&format=json

Transection of the oesophagus for bleeding oesophageal varices

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

Estimation of hepatic blood flow with indocyanine green

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

Galactose elimination capacity as a prognostic index in patients with fulminant liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

Correlation of caffeine elimination and Child's classification in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

[14C]aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Short report: interferon-alpha decreases 14C-aminopyrine breath test values in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Aminopyrine breath test predicts surgical risk for patients with liver disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Predicting outcome of paracetamol poisoning by use 14C-aminopyrine breath test

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Non-invasive evaluation of portal-systemic shunting in man by D-sorbitol bioavailability

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Liver regeneration and restoration of liver function after partial hepatectomy in patients with liver tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021

Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210104.X

7 January 2021